DIFFERENT HLA DR-DQ ASSOCIATIONS IN SUBGROUPS OF IDIOPATHIC MYASTHENIA-GRAVIS

被引:64
|
作者
CARLSSON, B
WALLIN, J
PIRSKANEN, R
MATELL, G
SMITH, CIE
机构
[1] SODER SJUKHUSET, DEPT NEUROL, CTR MYASTHENIA GRAVIS, STOCKHOLM, SWEDEN
[2] KAROLINSKA INST, HUDDINGE UNIV HOSP, NOVUM, DEPT CLIN IMMUNOL, S-14152 HUDDINGE, SWEDEN
关键词
D O I
10.1007/BF02115001
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have investigated the HLA-DRB and -DQB gene polymorphism in 131 myasthenia gravis (MG) patients. The HLA genotypes in these patients were assigned by means of restriction fragment length polymorphism (RFLP)-defined DR-DQ haplotypes, correlating to serologic HLA class II typing. Using this technique we could, among randomly selected non-thymomatous (NT)-MG patients, confirm the strong association to DR3, and 70% of the patients were found to carry a specific DR3-positive DR-DQ haplotype, T-3.1. Furthermore, an analysis of T-3.1- NT-MG patients revealed that 59 % were T-4.1÷ (DR4, DQw8). Thymic hyperplasia was found in approximately 85 % of the T-3.1+, as well as of the T-4.1+ /3.1- patients. As previously observed, we found a clear dominance of females among the T-3.1+ NT-MG patients. However, among T-4.1+/3.1- patients, males were as common as females. Furthermore, the T-4.1+ patients were significantly older at the onset of disease than those who were T-3.1+. In female MG patients, the DRwl5-Dw2-positive haplotype T-2.1 was strongly correlated with the presence of thymoma (T-MG). These data indicate that the HLA associations in early vs late onset of NT-MG are different, and that female patients with and without thymoma differ from each other with regard to HLA markers. Thus, at least three different HLA DR-DQ associations are found in subgroups of idiopathic MG. © 1990 Springer-Verlag.
引用
收藏
页码:285 / 290
页数:6
相关论文
共 50 条
  • [21] MYASTHENIA-GRAVIS AND HLA PHENOTYPES IN JAMAICANS
    BARTON, EN
    SMIKLE, M
    MORGAN, OSC
    SOUTHERN MEDICAL JOURNAL, 1992, 85 (09) : 904 - 906
  • [22] ON CALL DRAMA: DR-DQ ASSOCIATIONS STRIKE BACK!
    Nowak, Paulina
    Atkinson, Evan
    Heneghan, Jean
    Crowe, Deborah
    HUMAN IMMUNOLOGY, 2017, 78 : 245 - 245
  • [23] HLA DR-DQ ASSOCIATIONS WITH CERVICAL-CARCINOMA SHOW PAPILLOMAVIRUS-TYPE SPECIFICITY
    APPLE, RJ
    ERLICH, HA
    KLITZ, W
    MANOS, MM
    BECKER, TM
    WHEELER, CM
    NATURE GENETICS, 1994, 6 (02) : 157 - 162
  • [24] Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis
    Perdriger, A
    Chales, G
    Semana, G
    Guggenbuhl, P
    Meyer, O
    Quillivic, F
    Pawlotsky, Y
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (07) : 1272 - 1276
  • [25] ASSOCIATION OF HLA ANTIGENS WITH MYASTHENIA-GRAVIS IN CHINESE
    CHIU, HC
    HSIEH, RP
    HSIEH, KH
    HUNG, TP
    JOURNAL OF NEUROIMMUNOLOGY, 1987, 16 (01) : 32 - 32
  • [26] HLA AND MYASTHENIA-GRAVIS - 3 CATEGORIES OF SUBDIVISION
    ELCHIDIAC, A
    LEPAGE, V
    BERRIH, S
    COLOMBANI, J
    DEGOS, L
    PATHOLOGIE BIOLOGIE, 1985, 33 (01): : 50 - 54
  • [27] HLA ANTIGENS IN PENICILLAMINE INDUCED MYASTHENIA-GRAVIS
    VINCENT, A
    NEWSOMDAVIS, J
    BRITISH MEDICAL JOURNAL, 1983, 286 (6368): : 893 - 893
  • [28] INVOLVEMENT OF HLA IN CLINICAL COURSES OF MYASTHENIA-GRAVIS
    HAYASHI, M
    KIDA, K
    YAMADA, I
    MATSUDA, H
    SONODA, S
    INOUE, H
    SHIGA, S
    JOURNAL OF NEUROIMMUNOLOGY, 1988, 18 (02) : 171 - 179
  • [29] HLA AND MYASTHENIA-GRAVIS - 3 CATEGORIES OF SUBDIVISION
    ELCHIDIAC, A
    LEPAGE, V
    BERRIH, S
    COLOMBANI, J
    DEGOS, L
    SEMAINE DES HOPITAUX, 1985, 61 (25): : 1821 - 1825
  • [30] HLA ANTIGENS IN JAPANESE PATIENTS WITH MYASTHENIA-GRAVIS
    MATSUKI, K
    JUJI, T
    TOKUNAGA, K
    TAKAMIZAWA, M
    MAEDA, H
    SODA, M
    NOMURA, Y
    SEGAWA, M
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02): : 392 - 399